Skip to main content
Clinical Trials/NCT02987985
NCT02987985
Completed
Phase 3

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy: a Pilot Study

University of Saskatchewan1 site in 1 country50 target enrollmentOctober 15, 2017

Overview

Phase
Phase 3
Intervention
Acetaminophen, gabapentin
Conditions
Pathologic Processes
Sponsor
University of Saskatchewan
Enrollment
50
Locations
1
Primary Endpoint
Respiratory depression
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, lidocaine, and gabapentin can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative respiratory depression in children with sleep-disordered breathing.

Detailed Description

The objective of this trial is to determine whether an opioid-free general anesthetic can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques.

Registry
clinicaltrials.gov
Start Date
October 15, 2017
End Date
December 20, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jonathan Gamble

Principle Investigator

University of Saskatchewan

Eligibility Criteria

Inclusion Criteria

  • Patients aged 0-12 years with Sleep Disordered Breathing (SDB) who are scheduled for elective Tonsillectomy/AdenoTonsillectomy (T/AT) will be recruited at Royal University Hospital, Saskatoon, Saskatchewan.

Exclusion Criteria

  • age \> 12; American Society of Anesthesiologists (ASA) Classification \> IV; significant cardiorespiratory, neurological, craniofacial, hepatic, renal, or genetic disorders, excluding SDB; concomitant surgical procedures other than myringotomy and tubes; and allergy to any of the study drugs

Arms & Interventions

Opioid-free anesthesia

Opioid-free preoperative medications, Opioid-free pre-intubation medications, Opioid-free maintenance medication, postoperative nausea and vomiting prophylaxis

Intervention: Acetaminophen, gabapentin

Opioid-free anesthesia

Opioid-free preoperative medications, Opioid-free pre-intubation medications, Opioid-free maintenance medication, postoperative nausea and vomiting prophylaxis

Intervention: Ketamine , Lidocaine , Dexmedetomidine

Opioid-free anesthesia

Opioid-free preoperative medications, Opioid-free pre-intubation medications, Opioid-free maintenance medication, postoperative nausea and vomiting prophylaxis

Intervention: Dexamethasone , Ondansetron

Opioid-free anesthesia

Opioid-free preoperative medications, Opioid-free pre-intubation medications, Opioid-free maintenance medication, postoperative nausea and vomiting prophylaxis

Intervention: Sevoflurane

Opioid-sparing anesthesia

Opioid-sparing preoperative medications, Opioid sparing pre-intubation medications, Opioid-sparing maintenance medications, postoperative nausea and vomiting prophylaxis

Intervention: Acetaminophen

Opioid-sparing anesthesia

Opioid-sparing preoperative medications, Opioid sparing pre-intubation medications, Opioid-sparing maintenance medications, postoperative nausea and vomiting prophylaxis

Intervention: Fentanyl, Dexmedetomidine

Opioid-sparing anesthesia

Opioid-sparing preoperative medications, Opioid sparing pre-intubation medications, Opioid-sparing maintenance medications, postoperative nausea and vomiting prophylaxis

Intervention: Dexamethasone , Ondansetron

Opioid-sparing anesthesia

Opioid-sparing preoperative medications, Opioid sparing pre-intubation medications, Opioid-sparing maintenance medications, postoperative nausea and vomiting prophylaxis

Intervention: Sevoflurane, Fentanyl

Outcomes

Primary Outcomes

Respiratory depression

Time Frame: 24 hours following surgery

Number of desaturation events (oxygen saturation by pulse oximetry (SPO2) \<90%) as measured by a Masimo Radical-7 pulse oximeter during the first postoperative night's sleep

Secondary Outcomes

  • Quantified opioid consumption(24 hours following surgery)
  • Pediatric Agitation Emergence Delirium (PAED) scale(24 hours following surgery)
  • Face Legs Activity Cry Consolability (FLACC) scale(24 hours following surgery)
  • Time until Post Anesthesia Care Unit (PACU) discharge readiness(24 hours following surgery)
  • Other adverse effects(24 hours following surgery)

Study Sites (1)

Loading locations...

Similar Trials